Cargando…
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
The pluripotency transcription factor NANOG has been implicated in tumor development, and NANOG-expressing cancer cells manifest stem cell properties that sustain tumor homeostasis, mediate therapy resistance and fuel tumor progression. However, how NANOG converges on somatic circuitry to trigger on...
Autores principales: | Jeter, Collene R, Liu, Bigang, Lu, Yue, Chao, Hsueh-Ping, Zhang, Dingxiao, Liu, Xin, Chen, Xin, Li, Qiuhui, Rycaj, Kiera, Calhoun-Davis, Tammy, Yan, Li, Hu, Qiang, Wang, Jianmin, Shen, Jianjun, Liu, Song, Tang, Dean G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109294/ https://www.ncbi.nlm.nih.gov/pubmed/27867534 http://dx.doi.org/10.1038/celldisc.2016.41 |
Ejemplares similares
-
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018) -
miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells
por: Liu, Ruifang, et al.
Publicado: (2016) -
Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA−/lo castration-resistant cells
por: Rycaj, Kiera, et al.
Publicado: (2016) -
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011) -
Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species
por: Liu, Bigang, et al.
Publicado: (2014)